Primed IFN-γ-Umbilical Cord Stem Cells Ameliorate Temporomandibular Joint Osteoarthritis
Tissue Engineering Part A · 2025
DOI: 10.1089/ten.tea.2023.0370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue Engineering Part A, 2025. Verfasst von Yerin Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: AMIST, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea. Hauptthemen laut MEDLINE: Osteoarthritis, Mesenchymal Stem Cells, Umbilical Cord, Interferon-gamma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Temporomandibular joint osteoarthritis (TMJOA) is a degenerative disorder affecting the temporomandibular joint (TMJ), marked by persistent inflammation and structural damage to the joint. Only symptomatic treatment is available for managing TMJOA. Human umbilical cord mesenchymal stem cells (hUC-MSCs) show potential for treating TMJOA via their immune-modulating actions in the disease area. In addition, stimulation of inflammatory cytokines such as interferon-gamma in hUC-MSCs improves the therapeutic activity of naïve stem cells. Emerging evidence indicates that macrophages play significant roles in regulating joint inflammation through diverse secreted mediators in the pathogenesis of TMJOA. This study was conducted to evaluate the effects of inflammatory cytokine-stimulated hUC-MSCs in repairing TMJOA-induced cartilage lesions and the role of macrophages in the disease. Our in vitro data showed that stimulated hUC-MSCs induce M2 polarization of macrophages and enhance the expression of anti-inflammatory molecules. These effects were subsequently validated in vivo . In a rat model of TMJOA, stimulated hUC-MSCs ameliorated inflammation and increased M2 macrophages ratio. Our results indicate that hUC-MSCs stimulated by inflammatory cytokines modulate the activation of M2 macrophages, thereby shifting the local osteoarthritis microenvironment toward a prochondrogenic state and facilitating cartilage repair in inflammatory conditions. Stimulating hUC-MSCs with inflammatory cytokines could potentially offer an effective therapeutic approach for TMJOA, with macrophages playing a pivotal role in immune modulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AMIST, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
- Asan Institute for Life Science, Asan Medical Center, Asan Medical Institute of Convergence Science and Technology, Seoul, Korea.
- Department of Oral and Maxillofacial Surgery, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
ORCID-Profile: Bu-Kyu Lee
Zitieren
APA
Kim, Y., Kim, H., Yun, S. Y., & Lee, B. K. (2025). Primed IFN-γ-Umbilical Cord Stem Cells Ameliorate Temporomandibular Joint Osteoarthritis. Tissue Engineering Part A. https://doi.org/10.1089/ten.tea.2023.0370
Vancouver
Kim Y, Kim H, Yun SY, Lee BK. Primed IFN-γ-Umbilical Cord Stem Cells Ameliorate Temporomandibular Joint Osteoarthritis. Tissue Engineering Part A. 2025. doi:10.1089/ten.tea.2023.0370
BibTeX
@article{Kim2025,
author = {Kim, Yerin and Kim, Hyunjeong and Yun, So-Yeon and Lee, Bu-Kyu},
title = {Primed IFN-γ-Umbilical Cord Stem Cells Ameliorate Temporomandibular Joint Osteoarthritis},
journal = {Tissue Engineering Part A},
year = {2025},
doi = {10.1089/ten.tea.2023.0370}
}
EUVIMED